Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson’s disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2020-01-01
|
| Series: | Translational Medicine of Aging |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468501120300171 |